Stay updated on Azacitidine and Pembrolizumab in MDS Clinical Trial

Sign up to get notified when there's something new on the Azacitidine and Pembrolizumab in MDS Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Azacitidine and Pembrolizumab in MDS Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    The page changes from a 403 Forbidden response to the ClinicalTrials.gov record for the azacitidine and pembrolizumab study, displaying its overview, eligibility criteria, treatment plan, outcomes, investigators, and study documents.
    Difference
    51%
    Check dated 2026-11-08T14:35:45.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.2 to v3.8.0, while the page still displays a 403 Forbidden error instead of the study record.
    Difference
    0.2%
    Check dated 2026-11-01T15:48:14.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    A notice announces NIH’s transition from using “Artificial Intelligence” to “Super Intelligence” terminology and links to transition updates and FAQs.
    Difference
    1%
    Check dated 2026-10-25T15:45:27.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    The footer revision identifier changes from v3.7.1 to v3.7.2 on the ClinicalTrials.gov error page.
    Difference
    0.2%
    Check dated 2026-10-18T15:48:09.000Z thumbnail image
  6. Check
    39 days ago
    Change Detected
    Summary
    The footer revision identifier changes from v3.7.0 to v3.7.1 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-11T15:48:11.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden message with minimal navigation, replacing the previously expected study-record content.
    Difference
    19%
    Check dated 2026-09-20T20:04:10.000Z thumbnail image

Stay in the know with updates to Azacitidine and Pembrolizumab in MDS Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Azacitidine and Pembrolizumab in MDS Clinical Trial page.